Janne Uurinmäki (@juurinmaki) 's Twitter Profile
Janne Uurinmäki

@juurinmaki

Isä, yrittäjä, partner, ICT, HSEQ, Lean Six Sigma GB, DevOps, Agile, (työ)turvallisuus. jatkuva kehittäminen ja lapinkuumeinen vaeltava perhokalastaja.

ID: 899319901059510272

calendar_today20-08-2017 17:19:07

3,3K Tweet

460 Followers

86 Following

Africa CDC (@africacdc) 's Twitter Profile Photo

Today, #Ethiopia makes history as the first country to launch the R21/Matrix-M malaria vaccine, delivered alongside insecticide-treated nets to protect children in 58 high-burden districts. With 186,000 doses ready for rollout, this integrated approach provides double protection

Today, #Ethiopia makes history as the first country to launch the R21/Matrix-M malaria vaccine, delivered alongside insecticide-treated nets to protect children in 58 high-burden districts.

With 186,000 doses ready for rollout, this integrated approach provides double protection
Janne Uurinmäki (@juurinmaki) 's Twitter Profile Photo

"..this fall, Sanofi is responsible for the commercialization of Nuvaxovid... product has a 6-month shelf life and has already begun shipping to healthcare providers and local retailers in the US." Hopefully it will be available also in the EU very soon. ir.novavax.com/press-releases…

Biff #SARSisAirborne 🍉 (@biff234523) 's Twitter Profile Photo

At today’s ACIP, they voted on COVID-19 vaccine recommendations, and thankfully we got exactly what we were hoping for, all things considered. Vote #4 is the actual recommendation - and the only one that has a legally binding element - and it re-affirms the use of shared

At today’s ACIP, they voted on COVID-19 vaccine recommendations, and thankfully we got exactly what we were hoping for, all things considered. 

Vote #4 is the actual recommendation - and the only one that has a legally binding element - and it re-affirms the use of shared
Daniel Park (@daniel_e_park) 's Twitter Profile Photo

Lost in the recent ACIP meeting: A lack of distinction between non-mRNA Novavax & mRNA. They voted on restrictions largely based on mRNA-specific concerns (many false assertions) when these issues flat-out don't apply to Novavax. A brief overview

Daniel Park (@daniel_e_park) 's Twitter Profile Photo

Summary: Six tenuous or wrong claims about COVID vaccines drove new restrictions. Four are irrelevant to protein-based Novavax, two only mildly so, yet the less-reactogenic NVX gets lumped in anyway. Hopefully future discussions are more nuanced. x.com/Daniel_E_Park/…

Biff #SARSisAirborne 🍉 (@biff234523) 's Twitter Profile Photo

Some good news from Sanofi: They are telling us that a locator tool for Novavax will be going live late next week. So, if things work out like they’re supposed to, Friesein and I might only have about 10 more days of hard work to do, and the rest of y’all might only have about

Biff #SARSisAirborne 🍉 (@biff234523) 's Twitter Profile Photo

Sanofi’s Novavax/Nuvaxovid webpage for Healthcare Professionals is now live: pro.campus.sanofi/us/products/nu… It includes a link to the new patient website, Nuvaxovid.com, which has not been activated yet, as well as a product locator at nuvaxovid.com/vaccine-locator, which is also

Sanofi’s Novavax/Nuvaxovid webpage for Healthcare Professionals is now live: pro.campus.sanofi/us/products/nu…

It includes a link to the new patient website, Nuvaxovid.com, which has not been activated yet, as well as a product locator at nuvaxovid.com/vaccine-locator, which is also
Daniel Park (@daniel_e_park) 's Twitter Profile Photo

#SaveTelehealth #LetAidIn #FreePalestine #Gaza A funny part of the conversation: Pharmacist: "So what do you do?" Me: "I'm an epidemiologist" Pharmacist: "oh that explains why you asked for the Novavax"

AJ Leonardi, MBBS, PhD (@fitterhappieraj) 's Twitter Profile Photo

I first wrote that covid was harming cells that controlled cancers in 2020. Why did you wait so long to tell the public? To gather data?

Raj Rajnarayanan (@rajlabn) 's Twitter Profile Photo

Tracking #SARSCoV2 #Lineages - Globally |09/29/25 Top lineages -#30DayTrends #G30 XFG (34.1%) XFG.3 (24.7%) NB.1.8.1 (11.5%) XFG.2 (7.1%) PQ.2 (4.6%) XFG.3.1 (2.9%) PE.1 (2.3%) PY.1 (1.1%) PQ.1 (0.9%) Tracker: public.tableau.com/app/profile/ra… 1/n

Tracking #SARSCoV2 #Lineages - Globally |09/29/25

Top lineages -#30DayTrends #G30 

XFG  (34.1%)
XFG.3  (24.7%)
NB.1.8.1  (11.5%)
XFG.2  (7.1%)
PQ.2  (4.6%)
XFG.3.1  (2.9%)
PE.1  (2.3%)
PY.1  (1.1%)
PQ.1  (0.9%)

Tracker:  public.tableau.com/app/profile/ra… 1/n
Jammer (@acrossthemersey) 's Twitter Profile Photo

New study in The Lancet Infectious Disease analyzing 460,000 patients across 40 US hospitals found that children’s risk of developing LongCOVID more than doubled upon reinfection, with no significant variation by vaccination status.

New study in The Lancet Infectious Disease analyzing 460,000 patients across 40 US hospitals found that children’s risk of developing LongCOVID more than doubled upon reinfection, with no significant variation by vaccination status.
Raj Rajnarayanan (@rajlabn) 's Twitter Profile Photo

Tracking #SARSCoV2 #Lineages - Globally |10/06/25 Top lineages -#30DayTrends #G30 XFG.3 (9.1%) NB.1.8.1 (6.1%) XFG.2 (5.4%) XFG.3.4.1 (4.7%) XFG.5.1 (3.7%) XFG.4.1 (3.4%) PQ.2 (3.1%) XFG (2.7%) PQ.17 (2.6%) XFG.8 (2.5%) Tracker: public.tableau.com/app/profile/ra… 1/n

Tracking #SARSCoV2 #Lineages - Globally |10/06/25

Top lineages -#30DayTrends #G30 

XFG.3  (9.1%)
NB.1.8.1  (6.1%)
XFG.2  (5.4%)
XFG.3.4.1  (4.7%)
XFG.5.1  (3.7%)
XFG.4.1  (3.4%)
PQ.2  (3.1%)
XFG  (2.7%)
PQ.17  (2.6%)
XFG.8  (2.5%)

Tracker:  public.tableau.com/app/profile/ra… 1/n
Anne Nova 🧚‍♀️ (@anne_nova2) 's Twitter Profile Photo

This is huge! $NVAX According to the Israeli ministry of health the transfer from Moderna Spikevax JN.1 to Novavax JN.1 will be on the 1st November. From November 1st on, ONLY Novavax will be available in Israel. The vaccine is free of charge. Recommendations: 12-65Y once a

Vipin M. Vashishtha (@vipintukur) 's Twitter Profile Photo

A NEW review explores how SARS-CoV-2 may influence cancer risk. ➡️ Unlike classical oncogenic viruses, it doesn’t insert viral oncogenes. Instead, its proteins: -Inhibit tumor suppressors -Activate growth, survival & inflammation pathways 👉 Potential role in cancer initiation

A NEW review explores how SARS-CoV-2 may influence cancer risk.

➡️ Unlike classical oncogenic viruses, it doesn’t insert viral oncogenes. Instead, its proteins:

-Inhibit tumor suppressors
-Activate growth, survival & inflammation pathways

👉 Potential role in cancer initiation
Janne Uurinmäki (@juurinmaki) 's Twitter Profile Photo

'Novavax has completed the transfer of the marketing authorization for its COVID-19 vaccine, Nuvaxovid® to Sanofi, in the European Union (EU) enabling Sanofi to take full responsibility for commercial and regulatory activities in the EU. " ir.novavax.com/press-releases…

Don Ford - The People's Strategist - (@doneford) 's Twitter Profile Photo

A lot of people have fought me about whether Novavax has an upper respiratory tract response; spoilers: it does. I can't say what those motivations are, but I can say very openly that they were and are wrong. onlinelibrary.wiley.com/doi/10.1002/jm… Novavax's study proving it by creating a new

CryptoVision (@newxvg) 's Twitter Profile Photo

NOVAVAX $NVAX breaking news! 💥 BREAKING: Peer-reviewed data just dropped — $NVAX vaccine triggers mucosal immunity (IgA in saliva). That’s protection where infection starts — something mRNA shots never pulled off. This is real biotech. Real immunity. Real value. Study →